Deals & Cases

10 von 538 Einträgen wurden gefunden.
2019-09-05

These are the first benchmark deals of Credit Suisse Group AG using interest rates that are based on one of the new risk-free rates established as an alternative to LIBOR, and the AT1 issuance is the first public issuance in the Swiss market to reset over mid-swaps based on SARON.

These are the first benchmark deals of Credit Suisse Group AG using interest rates that are based on one of the new risk-free rates established as an alternative to LIBOR, and the AT1 issuance is the first public issuance in the Swiss market to reset over mid-swaps based on SARON. Homburger advised Credit Suisse on the structuring, documentation and launch of these innovative transactions. Homburger also recently supported the National Working Group for Reference Rates in Swiss Francs in the development of preferred interest rate provisions for SARON floating rate notes, including sample fallback language.


The Homburger Team included partners René Bösch and Benjamin Leisinger (both Banking and Finance and Capital Markets) as well as Dieter Grünblatt (Tax), Lee Saladino (Counsel, Capital Markets) and Andrea Ziswiler (Associate, Banking and Finance and Capital Markets).

Mehr lesen
2019-09-05

On September 4, 2019, UBS Group AG (the Issuer) successfully completed the issuance of SGD 750 m 4.85 per cent. Tier 1 Capital Notes (the Notes).

On September 4, 2019, UBS Group AG (the Issuer) successfully completed the issuance of SGD 750 m 4.85 per cent. Tier 1 Capital Notes (the Notes). The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG's Swiss going concern requirements.


The Notes feature a full contractual write-down if (among other events) UBS Group AG's consolidated common equity tier 1 capital falls below 7 per cent. of its consolidated risk weighted assets (a so-called "Trigger Event"). This means that, in the case of the occurrence of a Trigger Event, the Notes will be fully written-down prior to, or at the latest concurrently with, UBS Group AG's other outstanding (high-trigger and low-trigger) regulatory capital write-down instruments. Since the Notes are eligible to fulfill Swiss going concern requirements, they also qualify for an exemption from the Swiss withholding tax that would normally be applicable to bonds directly issued by the Swiss-domiciled Issuer. The Notes are traded on the SIX Swiss Exchange.


Homburger advised UBS with respect to all regulatory and transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher, Stefan Kramer (both Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsels Lee Saladino and Eduard De Zordi and associate Olivier Baum (all Banking and Finance | Capital Markets).

Mehr lesen
2019-09-03

On August 27, 2019, UBS Group AG (the Issuer) successfully completed the issuance of AUD 700 m 4.375 per cent. Tier 1 Capital Notes (the Notes).

On August 27, 2019, UBS Group AG (the Issuer) successfully completed the issuance of AUD 700 m 4.375 per cent. Tier 1 Capital Notes (the Notes). The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG's Swiss going concern requirements.


The Notes feature a full contractual write-down if (among other events) UBS Group AG's consolidated common equity tier 1 capital falls below 7 per cent. of its consolidated risk weighted assets (a so-called "Trigger Event"). This means that, in the case of the occurrence of a Trigger Event, the Notes will be fully written-down prior to, or at the latest concurrently with, UBS Group AG's other outstanding (high-trigger and low-trigger) regulatory capital write-down instruments. Since the Notes are eligible to fulfill Swiss going concern requirements, they also qualify for an exemption from the Swiss withholding tax that would normally be applicable to bonds directly issued by the Swiss-domiciled Issuer. The Notes are traded on the SIX Swiss Exchange.


Homburger advised UBS with respect to all regulatory and transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher, Stefan Kramer (both Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsels Lee Saladino and Eduard De Zordi and associate Olivier Baum (all Banking and Finance | Capital Markets).

Mehr lesen
2019-08-22

On August 14, 2019, Credit Suisse Group AG (CSG) launched, and on August 21, 2019, CSG successfully completed, the issuance of USD 1.75 bn 6.375 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes (the Notes).

On August 14, 2019, Credit Suisse Group AG (CSG) launched, and on August 21, 2019, CSG successfully completed, the issuance of USD 1.75 bn 6.375 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes (the Notes). The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill CSG's Swiss going concern requirements.


The Notes feature a full contractual write-down if (among other events) CSG's consolidated common equity tier 1 capital falls below 7 per cent. of its consolidated risk weighted assets (a so-called "Contingency Event"). This means that, in the case of the occurrence of a Contingency Event, the Notes will be fully written-down prior to, or at the latest concurrently with, CSG's other outstanding (high-trigger and low-trigger) regulatory capital write-down instruments. Since the Notes are eligible to fulfill Swiss going concern requirements, they also qualify for an exemption from the Swiss withholding tax that would normally be applicable to bonds directly issued by the Swiss-domiciled CSG. The Notes are traded on the SIX Swiss Exchange.


Homburger advised Credit Suisse with respect to all aspects of Swiss law. The Homburger team was led by partner René Bösch (Capital Markets) and included partners Benjamin Leisinger (Capital Markets) and Dieter Grünblatt (Tax), as well as counsel Lee Saladino and associates Andreas Josuran, Andrea Ziswiler and Olivier Baum (all Capital Markets).


Mehr lesen
2019-08-20

On August 20, 2019, KBL European Private Bankers S.A. (KBL epb), a pan-European private banking group headquartered in Luxembourg and operating in 50 cities across Europe, announced that it has entered into an agreement to acquire Bank am Bellevue AG (Bank), the wealth management business of the independent Swiss financial boutique Bellevue Group AG listed on the SIX Swiss Exchange.

On August 20, 2019, KBL European Private Bankers S.A. (KBL epb), a pan-European private banking group headquartered in Luxembourg and operating in 50 cities across Europe, announced that it has entered into an agreement to acquire Bank am Bellevue AG (Bank), the wealth management business of the independent Swiss financial boutique Bellevue Group AG listed on the SIX Swiss Exchange.


The acquisition of the Bank – which currently employs 22 staff and manages some CHF 1.7 bn in assets – marks KBL epb’s return to Switzerland as part of its growth strategy, under the leadership of Jürg Zeltner, who was recently appointed Group CEO and member of the Board of Directors of KBL epb.


The Homburger team advising KBL epb in this transaction was led by partner Daniel Hasler (Corporate | M&A) and included partner Benjamin Leisinger (Banking and Finance), associates Nina Hagmann (Corporate | M&A), Michael Kottmann (Employment Law and Executive Compensation), Luca Dal Molin (IP | IT) and junior associates Michael Lüchinger (Corporate | M&A) and Michèle Reinhardt (Competition | Regulatory).

Mehr lesen
2019-08-19

On August 6, 2019, Robert Bosch Venture Capital, the corporate venture capital company of the Bosch Group, announced that it had led a USD 17.5 m investment in Teralytics AG, together with Deutsche Bahn Digital Ventures, innogy Ventures, LBBW Venture Capital, Liil Ventures, Atomico and Lakestar.

On August 6, 2019, Robert Bosch Venture Capital, the corporate venture capital company of the Bosch Group, announced that it had led a USD 17.5 m investment in Teralytics AG, together with Deutsche Bahn Digital Ventures, innogy Ventures, LBBW Venture Capital, Liil Ventures, Atomico and Lakestar. Teralytics is a Swiss software company that is building a platform to provide advanced mobility analytics powered by telecom network data. It uses proprietary artificial intelligence to extrapolate insights, anonymized and aggregated. This enables customers such as mobility providers, cities and transport services to understand, predict and improve people’s journeys.


Homburger has advised Robert Bosch Venture Capital in the investment.


The Homburger team was led by partners David Oser and Daniel Hasler and included associates Aron Waltuch and Olivier Bühlmann (all Corporate | M&A) as well as junior associate Isabelle Meier (IP | IT).


Mehr lesen
2019-08-15

On August 13, 2019, UBS Group AG (the Issuer) successfully completed its issuance of USD 1.5 bn principal amount of bail-inable (TLAC) notes (the Notes) under its Senior Debt Programme.

On August 13, 2019, UBS Group AG (the Issuer) successfully completed its issuance of USD 1.5 bn principal amount of bail-inable (TLAC) notes (the Notes) under its Senior Debt Programme. The Notes will be listed on the SIX Swiss Exchange.


The Notes are the first issuance of bail-inable (TLAC) notes under the Senior Debt Programme by UBS Group AG as Issuer. The Notes were also placed in the United States with QIBs in reliance on Rule 144A.


As with bail-inable (TLAC) notes previously issued by other UBS entities, the Notes are designed to allow FINMA to exercise its statutory resolution powers to write-down the Notes and|or convert them into equity of UBS Group AG should restructuring proceedings be opened with respect to UBS Group AG.


Structural subordination enables FINMA to fully or partially convert or write-down the Notes prior to the operating liabilities of the bank UBS AG.


Homburger advised UBS in the structuring of the transaction and on all regulatory and transactional aspects as to Swiss law of the offer, the issuance of the Notes and the listing on the SIX Swiss Exchange.


The Homburger team included partners Stefan Kramer (Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as associates Andreas Josuran and Andrea Ziswiler (both Banking and Finance | Capital Markets).

Mehr lesen
2019-07-18

In June 2019, Credit Suisse (Schweiz) AG (Credit Suisse Schweiz) established its CHF 20 bn Covered Bond Programme irrevocably guaranteed as to payments of interest and principal by Credit Suisse (Schweiz) Hypotheken AG (the Programme), and on July 16, 2019, Credit Suisse Schweiz successfully completed its inaugural issuance of CHF 250 m 0.000% Fixed Rate Covered Bonds due 2029 thereunder.

In June 2019, Credit Suisse (Schweiz) AG (Credit Suisse Schweiz) established its CHF 20 bn Covered Bond Programme irrevocably guaranteed as to payments of interest and principal by Credit Suisse (Schweiz) Hypotheken AG (the Programme), and on July 16, 2019, Credit Suisse Schweiz successfully completed its inaugural issuance of CHF 250 m 0.000% Fixed Rate Covered Bonds due 2029 thereunder. The Covered Bonds are indirectly backed by a portfolio of domestic mortgages originated by Credit Suisse Schweiz.


The Programme is the first Swiss law governed structured Covered Bond Programme of a Swiss G-SIB and it allows Credit Suisse Schweiz to further diversify its long-term funding sources.


Homburger advised Credit Suisse (Schweiz) AG as Issuer. The Homburger team was led by partner Stefan Kramer (Banking and Finance | Capital Markets) and included partners Benjamin Leisinger (Banking and Finance | Capital Markets) and Dieter Grünblatt (Tax) as well as associate David Borer (Banking and Finance).

Mehr lesen
2019-07-16

On July 1, 2019, Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announced the completion of the acquisition of Atracsys Sàrl, the Switzerland-based provider of optical tracking technology used in computer-assisted surgery.

On July 1, 2019, Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announced the completion of the acquisition of Atracsys Sàrl, the Switzerland-based provider of optical tracking technology used in computer-assisted surgery. The acquisition supports Smith & Nephew’s long-term commitment to develop its multi-asset digital surgery and robotics ecosystem to empower surgeons and improve clinical outcomes.


Atracsys’ fusionTrack 500 optical tracking camera will be a core enabling technology for Smith & Nephew’s next-generation robotics platform, due for commercial release in 2020. The fusionTrack 500 offers superior measurement speed and latency performance, supporting reduced procedure times, as well as increased accuracy resulting in finer precision surgical tasks, such as bone cuts, compared to existing tracking technology.


Homburger provided Swiss law advice to Smith & Nephew in its acquisition of Atracsys Sàrl. The Homburger team was led by partner David Oser (Corporate | M&A) and included counsel Micha Fankhauser, associate Olivier Bühlmann (both Corporate | M&A), counsel Peter Müller and associate Laetitia Fracheboud (both Tax) as well as associate Carola Winzeler (IP | IT).


Milbank acted as international counsel to Smith & Nephew.

Mehr lesen
2019-07-12

On July 9, 2019, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it had raised an aggregate of USD 103 m through a private placement of shares, bringing the total gross proceeds of its Series E financing round to USD 303 m.

On July 9, 2019, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it had raised an aggregate of USD 103 m through a private placement of shares, bringing the total gross proceeds of its Series E financing round to USD 303 m.


Homburger advised ADC Therapeutics SA in this matter. The Homburger team is led by partner Dieter Gericke (Corporate | M&A) and included partner Reto Heuberger (Tax) as well as associates Daniel Häusermann and Anna Peter and junior associate Nicolas Eckert (all Corporate | M&A).

Mehr lesen